Dementia Research Funding: Progress Made, But Still Lagging Behind

Dementia is one of the greatest health and social care challenges of our time, affecting nearly 1 million people in the UK. With an ageing population, this number is expected to rise, making dementia research more critical than ever. In recent years, there have been positive strides in funding, but despite these efforts, dementia research still lags significantly behind other conditions such as cancer.

The Growing Burden of Dementia

Dementia is an umbrella term for a range of progressive neurological disorders, including Alzheimer’s disease, vascular dementia, and dementia with Lewy bodies. These conditions cause memory loss, cognitive decline, and, ultimately, a loss of independence, placing a heavy emotional and financial strain on individuals, families, and the health and social care system.

The cost of dementia to the UK economy is estimated at £34.7 billion per year, a figure expected to rise to £94.1 billion by 2040 as the number of people living with dementia increases. Despite this economic impact, dementia research has historically been underfunded compared to other major health conditions.

How Dementia Research Funding Compares

Although dementia is the leading cause of death in the UK, research into the condition has long been overshadowed by other diseases, particularly cancer. In recent years, efforts have been made to redress this imbalance, but a significant funding gap remains:

• In 2022, cancer research funding in the UK totalled approximately £600 million, while dementia research funding was around £100 million.
• For every person living with cancer, around £360 is spent on research annually, compared to just £90 per person with dementia.
• The UK government pledged £160 million for dementia research as part of the Dementia Moonshot in 2019, but progress in delivering these funds has been slow.

This disparity is even more striking given that there are currently more people living with dementia than with cancer in the UK. While cancer research has seen remarkable advances in treatment and survival rates, dementia remains an area where breakthroughs are desperately needed.

Why Dementia Research Needs More Investment

There are several key reasons why increased funding for dementia research is crucial:

1. There Are No Effective Treatments

Unlike cancer, where early detection and advanced treatments have led to improved survival rates, dementia currently has no cure and no treatments that can halt or significantly slow its progression. Existing medications can only help manage symptoms for a limited time.

2. Dementia Research Has Historically Been Neglected

While conditions such as heart disease and cancer have benefitted from decades of substantial research investment, dementia funding only began to increase in the last decade. This historical underinvestment has delayed scientific progress.

3. The Social and Economic Impact Is Growing

Dementia is not just a health issue but a major social care challenge. Most people with dementia will require increasing levels of care, with many needing full-time residential support. Carers, often family members, provide an estimated £13.9 billion worth of unpaid care each year in the UK. Research into better treatments could reduce this burden.

4. Early Diagnosis and Prevention Need More Focus

Research into biomarkers, lifestyle interventions, and risk reduction has shown promise, but more funding is needed to develop tools that can identify dementia earlier and prevent its onset in high-risk individuals.

What Needs to Change?

To bridge the funding gap, dementia research needs:

• Sustained and increased investment from both government and private sector sources.
• Greater public awareness and advocacy to ensure dementia is prioritised in research funding decisions.
• A long-term commitment to dementia research, ensuring it receives the same level of focus as cancer and cardiovascular diseases.
• Support for innovative clinical trials to fast-track potential treatments.

The UK government has committed to doubling dementia research funding to £160 million per year, but it is crucial that this funding is delivered without delays and with a clear strategy for impact.

How You Can Help

While large-scale funding decisions are made at governmental and organisational levels, individuals can also play a role in supporting dementia research:

• Donate to dementia research charities, such as Alzheimer’s Research UK and the Alzheimer’s Society.
• Participate in research studies and trials, which are vital for advancing scientific understanding.
• Advocate for increased funding by engaging with MPs and raising awareness through social media.

Conclusion

The increase in dementia research funding in recent years is a step in the right direction, but it remains significantly behind other conditions such as cancer. Given the scale of the dementia crisis, further investment is urgently needed to drive breakthroughs in treatment, prevention, and care.

If we are to offer hope to the millions affected by dementia, we must continue to push for fair and sustainable research funding. Without it, we risk falling even further behind in the fight against this devastating condition.

---

Sources

1. Alzheimer’s Research UK. “Dementia Statistics Hub.” https://www.alzheimersresearchuk.org
2. Alzheimer’s Society. “The Cost of Dementia in the UK.” https://www.alzheimers.org.uk
3. UK Government. “Dementia Research Funding Announcement (2019).” https://www.gov.uk
4. Cancer Research UK. “Research Funding Overview.” https://www.cancerresearchuk.org
5. Office for National Statistics. “Leading Causes of Death in the UK.” https://www.ons.gov.uk